| 62.43 Data as of May 20 |  -1.58 / -2.47%Today’s Change | 34.30 Today|||52-Week Range 71.56 | +26.89% Year-to-Date |
| Cramer's 'Mad Money' Recap: Think Dividends, Not Coupons May 20 / TheStreet.com | 10 ASCO '13 Abstracts You Can Read Right Now May 15 / TheStreet.com |
| Biomarin Stock Falls On Unusually High Volume (BMRN) May 16 / TheStreet.com |
| Previous close | 64.01 |
| Today’s open | 63.91 |
| Day’s range | -- - -- |
| Volume | 1,345,417 |
| Average volume (3 months) | 1,304,143 |
| Market cap | $8.9B |
| Dividend yield | -- |
| Earnings growth (last year) | -97.92% |
| Earnings growth (this year) | -37.06% |
| Earnings growth (next 5 years) | +36.00% |
| Revenue growth (last year) | +10.96% |
| P/E ratio | NM |
| Price/Sales | 11.96 |
| Price/Book | 7.93 |
| Today’s change | Today’s % change | |
|---|---|---|
| FRXForest Laboratories ... | -0.55 | -1.43% |
| ONXXOnyx Pharmaceuticals... | -1.31 | -1.37% |
| PRGOPerrigo Co | -0.45 | -0.38% |
| RDYDr.Reddy's Laborator... | -0.27 | -0.71% |
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | -$0.29 |
| Annual revenue (last year) | $494.9M |
| Annual profit (last year) | -$114.3M |
| Net profit margin | -23.11% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Jean-Jacques Bienaimé, MBA |
Chief Financial Officer & Executive Vice President Daniel K. Spiegelman, MBA |
Corporate headquarters Novato, California |
.
